SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-16-149364
Filing Date
2016-10-07
Accepted
2016-10-07 16:54:52
Documents
7
Period of Report
2016-10-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a16-19448_48k.htm 8-K 29758
2 EX-1.1 a16-19448_4ex1d1.htm EX-1.1 225149
3 EX-5.1 a16-19448_4ex5d1.htm EX-5.1 14266
4 EX-99.1 a16-19448_4ex99d1.htm EX-99.1 8137
5 GRAPHIC g194484mmi001.gif GRAPHIC 7540
6 GRAPHIC g194484kmi001.gif GRAPHIC 2378
7 GRAPHIC g194484kmi002.gif GRAPHIC 9486
  Complete submission text file 0001104659-16-149364.txt   305699
Mailing Address 167 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 167 SIDNEY STREET CAMBRIDGE MA 02139 6176795500
IDERA PHARMACEUTICALS, INC. (Filer) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31918 | Film No.: 161928476
SIC: 2836 Biological Products, (No Diagnostic Substances)